Concepedia

Julie E. Bolding

JE

5

Publications

729

Citations

5

H-Index

2021

Active since

Affiliations

University of Copenhagen(Current)

École Polytechnique Fédérale de Lausanne

University of Chicago

East China Normal University

Julie E. Bolding is an author at University of Copenhagen specializing in drug discovery, chemical biology, and natural sciences.

ORCID

Top concepts

Publications per year

2021–2023

5

Publications

5

Class I histone deacetylases (HDAC1–3) are histone lysine delactylases

Carlos Moreno–Yruela, Di Zhang, Wei Wei et al. · Science Advances · 2022 · 593 citations · Full text

Class I Histone Deacetylases (HDAC1–3) are Histone Lysine Delactylases

Carlos Moreno–Yruela, Di Zhang, Wei Wei et al. · 2021 · 48 citations · Full text

Aryl Fluorosulfate Based Inhibitors That Covalently Target the SIRT5 Lysine Deacylase**

Julie E. Bolding, Pablo Martín‐Gago, Nima Rajabi et al. · Angewandte Chemie International Edition · 2022 · 42 citations · Full text

, , +15

Investigation of Carboxylic Acid Isosteres and Prodrugs for Inhibition of the Human SIRT5 Lysine Deacylase Enzyme**

Nima Rajabi, Tobias Hansen, Alexander L. Nielsen et al. · Angewandte Chemie International Edition · 2022 · 32 citations · Full text

, , +17

Substrates and Cyclic Peptide Inhibitors of the Oligonucleotide‐Activated Sirtuin 7**

Julie E. Bolding, Alexander L. Nielsen, Iben Jensen et al. · Angewandte Chemie International Edition · 2023 · 14 citations · Full text

Rows per page

1–5 of 5